ECHA’s official REACH Candidate List table shows n-hexane (EC 203-777-6; CAS 110-54-3) added to the Candidate List with date of inclusion 04-Feb-2026, identified as an SVHC under Article 57(f) (human health) for specific target organ toxicity after repeated exposure (STOT RE). This addition triggers downstream REACH Candidate List obligations for supply chains (e.g., Article 33 communication for articles, and related SVHC information management).
ECHA’s official REACH Candidate List table shows n-hexane included on the Candidate List with date of inclusion 04-Feb-2026. The listing indicates the SVHC identification basis under REACH Article 57(f) (equivalent level of concern) related to human health (specific target organ toxicity after repeated exposure). This triggers downstream REACH SVHC compliance duties (e.g., Article 33 communication for articles containing the SVHC above 0.1% w/w and related supply-chain information management).
ECHA indicates that regulatory information on the REACH SVHC Candidate List is available in the ECHA CHEM database, and that ECHA will continue maintaining the legacy Candidate List dataset (Candidate List table page) up to date until July 2026 as part of the transition. For compliance teams, this is an operational/data-access update: systems that scrape or reference the legacy Candidate List table should plan for the transition to ECHA CHEM and ensure list-monitoring workflows remain uninterrupted through and after the July 2026 transition timeframe.
ECHA’s Registry of SVHC intentions until outcome (the official pipeline/status tracker for planned SVHC identification work) is indicated in the research as updated on 4 February 2026. This does not itself add substances to the Candidate List, but it is a compliance-relevant tracking update because it signals potential upcoming SVHC identifications that could later trigger Article 33 communication and related downstream duties once substances are included on the Candidate List.
ECHA adopted a decision to update the REACH Candidate List of substances of very high concern (SVHC) on 4 February 2026, identifying two substances as SVHCs meeting Article 57 criteria: (1) 4,4′-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and its salts (toxic for reproduction; Article 57(c)) and (2) n-hexane (EC 203-777-6; CAS 110-54-3) (specific target organ toxicity after repeated exposure; Article 57(f) human health). Candidate List inclusion triggers downstream REACH SVHC obligations for suppliers (e.g., communication duties for articles when SVHC >0.1% w/w under Article 33 and potential Article 7 notification duties where applicable).
ECHA’s Registry of SVHC intentions until outcome indicates that SVHC identification process information has been available in ECHA CHEM since 16 September 2025 and that the registry list will continue to be maintained “for the time being.” The page shows a “Last updated 04 February 2026” date, signaling ongoing upkeep of the SVHC pipeline tracker. Compliance teams can use this as an authoritative reference for monitoring SVHC intentions/consultations/outcomes during the ECHA CHEM transition.
ECHA opened a public consultation on its 13th draft recommendation for prioritising Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation runs from 2 February 2026 to 2 May 2026. If finalised and later adopted by the European Commission, Annex XIV inclusion would introduce authorisation obligations (including latest application and sunset dates). Compliance teams should review the draft recommendation and background documents, assess portfolio impacts for listed SVHCs, and consider submitting comments.
ECHA opened a public consultation on its draft 13th recommendation for prioritising certain Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation period runs from 2 February 2026 to 2 May 2026. This is a key SVHC-to-authorisation pipeline milestone: affected manufacturers/importers/downstream users should review whether any of the recommended substances are in their supply chains and consider submitting comments, as future Annex XIV inclusion can lead to authorisation obligations and phase-out pressures.
ECHA published supporting documents for its Draft 13th Recommendation of priority substances for potential inclusion in REACH Annex XIV (Authorisation List), including draft Annex XIV entry structures and background/prioritisation documents. This is a draft/pipeline step (not yet a binding Annex XIV amendment), but it signals which SVHCs may be advanced toward authorisation requirements, informing early substitution planning and monitoring of latest application date/sunset date proposals once finalized by the European Commission.
ECHA opened a public consultation on its 13th draft recommendation for prioritising SVHCs for inclusion in REACH Annex XIV (Authorisation List). The recommendation status is shown as 'included in draft recommendation' with a consultation window from 02-Feb-2026 to 02-May-2026. While this is not yet a binding Annex XIV amendment, it is a key step toward future authorisation requirements (e.g., eventual latest application and sunset dates) for substances selected by the European Commission. Compliance teams should review whether any listed substances are used in their products/processes and consider submitting comments during the consultation period and preparing for potential downstream authorisation impacts if the Commission proceeds.
ECHA published the Draft 13th Recommendation and opened a public consultation (2 Feb 2026 to 2 May 2026) on prioritising four SVHCs for potential inclusion in the REACH Authorisation List (Annex XIV): bumetrizole (UV-326), UV-329, triphenyl phosphate, and 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one. This consultation is a key step in the SVHC-to-authorisation pathway; affected companies should assess uses and consider submitting evidence on uses, alternatives, and socio-economic impacts.
ECHA launched a public consultation on its draft recommendation to the European Commission to add four Candidate List substances to the REACH Authorisation List (Annex XIV). Compliance teams should monitor this pipeline step because Annex XIV inclusion can introduce authorisation obligations for continued use/placing on the market (subject to future sunset dates set in any eventual Annex XIV entries). The consultation is open for stakeholder input until 2 May 2026.
ECHA published highlights from its Member State Committee (MSC) December meeting noting agreement to identify n-hexane as a substance of very high concern (SVHC). This is a formal step in the SVHC identification process under REACH and signals likely downstream Candidate List inclusion, which is relevant for companies to anticipate future Article 33 communication and related supply-chain compliance impacts once formally listed.
ECHA reported that its Member State Committee agreed to identify n-hexane as a Substance of Very High Concern (SVHC). This committee agreement is a formal REACH SVHC process milestone that precedes Candidate List inclusion and signals that downstream obligations (e.g., article communication/notification once listed) are expected to follow when ECHA updates the Candidate List accordingly.
ECHA published its recommendation dated 18 November 2025 to the European Commission to include four SVHCs in REACH Annex XIV (Authorisation List): Melamine; S-(tricyclo[5.2.1.0²,⁶]deca-3-en-8(or 9)-yl) O-(isopropyl/isobutyl/2-ethylhexyl) O-(isopropyl/isobutyl/2-ethylhexyl) phosphorodithioate; Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide; and Barium diboron tetraoxide. This is a pre-legislative step that can lead to future authorisation requirements (latest application/sunset dates) if adopted into Annex XIV by the European Commission. Compliance teams should track these substances and evaluate potential substitution/authorisation strategies.
ECHA issued its final (12th) recommendation to the European Commission to include four Candidate List SVHCs in REACH Annex XIV (Authorisation List). While this is not yet a binding Annex XIV amendment, it is a concrete step in the SVHC-to-authorisation pipeline and signals potential future authorisation obligations (i.e., continued use/placing on the market after any future sunset dates would require authorisation unless exemptions apply). Compliance teams should monitor the Commission’s subsequent Annex XIV amendment process and begin evaluating uses and substitution plans for the recommended substances.
ECHA added DBDPE (EC 284-366-9; CAS 84852-53-9) to the REACH Candidate List as an SVHC on vPvB grounds (Article 57(e)). This triggers downstream SVHC obligations for supply-chain communication (Article 33) for articles containing the SVHC above 0.1% w/w, potential ECHA article notification duties where applicable, and Safety Data Sheet updates for EU/EEA suppliers of the substance (as such or in mixtures). Compliance teams should update substance and article SVHC screening, supplier declarations, and customer communication processes accordingly.
ECHA published highlights from its Member State Committee (MSC) October meeting stating the MSC agreed to identify 1,1'-(ethane-1,2-diyl)bis[pentabromobenzene] (DBDPE) as an SVHC. This is a key procedural step in the SVHC identification process and can precede future Candidate List inclusion, affecting future Article 33/Article 7(2) obligations once/if included on the Candidate List.
ECHA published/updated the REACH Candidate List on 25 June 2025 to add three substances identified as SVHCs: Reactive Brown 51 (Article 57(c), toxic for reproduction), 1,1,1,3,5,5,5-heptamethyl-3-[(trimethylsilyl)oxy]trisiloxane (M3T) (Article 57(e), vPvB), and decamethyltetrasiloxane (Article 57(e), vPvB). This Candidate List expansion affects SVHC-related compliance duties such as supply chain communication and SVHC tracking for mixtures/articles.
ECHA issued Decision D(2025)4165-DC confirming identification of certain substances as SVHCs and stating that ECHA shall publish and update the REACH Candidate List on 25 June 2025; the decision takes effect from 25 June 2025. The decision text cited in the research identifies, among others, Reactive Brown 51 (Repr. 1B; Article 57(c)) and the siloxanes 1,1,1,3,5,5,5-heptamethyl-3-[(trimethylsilyl)oxy]trisiloxane and decamethyltetrasiloxane (vPvB; Article 57(e)). For compliance teams, this triggers standard Candidate List obligations (e.g., article communication and SCIP where applicable) from the inclusion/publication date stated in the decision.